You searched for "Orbit"
Orbis UK release 2024 highlights video
Orbis UK have released their 2024 highlights video, revealing some of the incredible achievements their supporters helped make possible last year. The Orbis Flying Eye Hospital completed two sight-saving missions to Mongolia and Bangladesh. Orbis's clinical staff and Volunteer medical...
Sirolimus for lymphatic-venous malformation
This is a case report on the use of oral sirolimus in the treatment of lymphatic-venous malformations. This condition can often be sight-threatening when present in the orbit and traditional management options have included observation, sclerotherapy and surgery. Both sclerotherapy...
PD-1 and PD-L1 in exenteration specimens
This is an immunohistochemical study looking at variation in the expression of the programmed death-1 receptor (PD-1) and the programmed cell death ligand-1 (PD-L1), comparing cutaneous malignancies which invaded the orbit with uncomplicated nodular basal cell carcinomas. The authors retrospectively...
Carcinoid tumours
This is a retrospective review of 28 patients with carcinoid tumours affecting the orbit. The mean age at presentation of the orbital involvement was 62 years, with a slight female preponderance, and 21% had carcinoid syndrome. Proptosis and diplopia were...Behind the eyes: Unravelling the mystery of a painless progressive proptosis
Orbital fungal infections have the potential to give rise to serious complications. While these infections typically originate in the sinuses, patients may initially exhibit ocular symptoms. As a result of the diverse and often vague clinical manifestations (especially during the...Orbis launches podcast and vodcast series exploring cutting edge tech
A new podcast and vodcast series exploring cutting edge tech to curb rise in preventable blindness has been launched by international eye health charity, Orbis.
Bisphosphonates can cause orbital inflammation
The authors describe four patients with bisphosphonate induced orbital inflammation and review a further 25 cases in the literature. Intravenous zoledronate was the most common precipitant (76% of cases) with the mean time until onset of inflammation being three days...
